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Biomarkers in Occupational Cancer
Epidemiology: Considerations in Study
Design
by Richard B. Hayes'
Epidemiologic studies ofoccupational groups havebeencentral tothe identification ofhuman carcinogens.
The incorporation ofabiochemical component intooccupational studiesofcancer canexpandthepossibilities
for identifying human carcinogens and for understanding the disease process. Two epidemiologic studies of
occupation and cancer which include evaluation of biomarkers are described. The association of acetylator
phenotype with bladder cancer risk was studied in benzidine-exposed workers. The association of benzene-
related leukopenia with leukemia isbeingstudied inbenzene-exposed workers.These investigations illustrate
issues in the use ofbiomarkers in epidemiologic studies ofcancerrisk. Such studiesrequire the identification
and characterization of the population at risk. Disease susceptibility factors are amenable for inclusion in
these studies and can be statistically modeled as exposure-effect modifiers. Biomarkers of exposure are
mainly of importance in short-term longitudinal and cross-sectional studies of exposure and intermediate
outcomes and forvalidation ofother data sources. Several sources of error can affect the results ofmolecular
epidemiologic studies. Aside from minimizing laboratory error, consideration mustbe given in the design and
execution ofthese studies topotential problems insubjectselectionandfieldcollection ofbiologicsamplesand
other relevant data.
Introduction
Epidemiologic studies ofoccupational groups have been
central to the identiflcation ofhuman carcinogens. Ofthe
50 agents classified by the International Agency for Re-
search on Cancer as carcinogenic to humans, 27 are
occupation related (1). The incorporation of a biochemical
component into occupational studies of cancer can expand
possibilities for identifying human carcinogens and for
understanding the disease process. The use ofbiomarkers
in epidemiologic studies of cancer has been suggested for
measuring the magnitude of exposure to carcinogens, or
body burden; for characterizing the biologic response to
such exposures; and for identifying markers of disease
susceptibility (2-4).
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I shall discuss the use of biomarkers in two of our on-
going epidemiologic studies ofoccupational exposure and
cancer risk and describe general considerations in carry-
ing out and interpreting such studies. The focus of this
paper is the use ofbiomarkers in epidemiologic studies on
the relation between occupational exposure and tihe devel-
opment of cancer. First, a brief description of the epi-
demiologic method is given.
Epidemiologic Methods
Epidemiologyis the studyofthe frequencyofdisease in
populations, which is studied as a measure ofrisk. Risk is
considered in terms of environmental factors, such as
occupation, diet,tobacco use, andotherbehaviors,interms
ofpossiblegeneticfactors, such asfamilyhistoryofcancer,
and other factors, such as age and race. For example, the
increased frequencyofbladder cancerinworkers exposed
to benzidine is evidence for the role ofbenzidine in human
bladder cancer development.
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The epidemiologic study of cancer requires considera-
tion of exposure and disease development over extended
periods of time, typically several decades. In the cohort
study design, a statistical sample of the population of
interestisidentified (e.g.,workers in achemicalplant), and
subjects are classified into groups on the basis ofoccupa-
tional exposure and personal factors of interest, such as
year of birth and sex. The classification of occupational
exposure generally accounts for the level and period of
exposure, although other parameters such as peak
exposure mayalsobe ofinterest. The subsequent develop-
ment ofdisease in the exposed groups is then determined
and the frequency ofdisease compared astherelativerisk
ofdisease.
In the case-control study design, statistical samples of
cases and controls are selected from the studypopulation;
and historical exposure and personal factors of interest
are compared between the two study groups. As in the
cohort study design, exposure classification takes level
and periods of exposure into account. The case-control
study can be seen as a theoretical derivative ofthe cohort
study, in which the cases occurring during a period are
compared to asample ofthe studypopulation, thecontrols,
at risk during that time. Because ofthis similarity, case-
control studies provide the same information as cohort
studies about the relative risk ofdisease.
These and related study designs are also used in bio-
markerresearch forendpoints other than disease. Short-
term longitudinal studies, for example comparing pre-
exposure and post-exposure, are used to determine
changes in biomarkers over a short period. Cross-sec-
tional studies examine the association of various factors,
including biomarkers, at one point in time. These and
similar study designs are ofgreat importance for assess-
ing the short-term biochemical and biologic effects of
exposure and for studying the interrelationship of these
factors with disease susceptibility. Short-term longitudi-
nal and cross-sectional studies are the respective design
equivalents ofcohort and case-control studies, except for
the major difference that the full temporal aspect of
exposure, generally over many years, and subsequent
cancer development are not considered.
Twoon-goingstudies oftheassociationbetweenoccupa-
tional exposure and cancer risk that include biomarkers
are briefly described below. The description and following
discussion ofthese studies serve to illustrate issues in the
design and execution ofsuch studies.
N-Acetylation and Bladder Cancer
When examinedingeneralpopulation groups, slowacet-
ylation status and bladder cancer are onlyweakly associ-
ated (5), while studies of bladder cancer cases with
nonspecific occupational exposures showabout2- to 3-fold
risks (6,7). Cartwright et al. (8) found about a 17-fold risk
for bladder cancer associatedwith slow acetylation in dye
workers, and Hanke et al. (9) found an 8-fold risk in a
group of workers exposed to aromatic amines. These
strong findings in industrially exposed populations sug-
gest that acetylation rate may be important only when
exposures to aromatic amines are substantial, aswould be
found in the occupational setting.
In 1988, we began studies in an Asian population
exposed to benzidine to expand upon the previous epi-
demiologic studies. In this study we collaborated with W.
Bi ofthe Chinese Academy ofPreventive Medicine and F.
Kadlubar ofthe National CenterforToxicologic Research.
In the first phase ofthe study, we identified a cohort of
2030 males alive in 1972 who had worked for at least one
year between 1945 and 1977 in benzidine production and
use in three cities in China. Acomparison ofthe incidence
ratesforbladdercancerinthegeneralpopulationwiththat
in the benzidine-exposed group gave a 25-fold increase.
Producers ofbenzidine [relative risk (RR) = 45.7] were at
higher risk than users (RR = 20.9). Exposure to ben-
zidine was crudely categorized as low, medium, and high
exposure, on the basis of the occupational title of the
longest job held. The risk for bladder cancer was about
5-fold in the low-exposure group, increasing to 158-fold in
the high-exposure group (10). Although the "high-risk"
slow-acetylator phenotype is reported to be about half as
frequent in Asians (11), suggesting that they may be at
lower risk for aromatic amine-associated bladder cancer,
the RRforbladdercancerinourstudycohortseemedtobe
as high or higher than thatidentified in studies in Europe
(12,13) and the United States (14).
To follow up on these findings, we carried out a case-
control studytoexamine therelationshipbetween acetyla-
tion phenotype, benzidine exposure, and bladder cancer
risk. Thirty-nine surviving, pathologically confirmed,
benzidine-exposed bladder cancer cases and 39 benzidine-
exposed controls with negative urine cytology were
selectedforstudy.Acetylationphenotypingwith acaffeine
dose (15) and urinary cotinine determination (16) were
carried out. Information was collected on occupational
history and smoking habits.
As compared tothe controls, cases had ahigherhistorical
level ofexposure tobenzidine (p < 0.01) and greatertobacco
use(p > 0.05).About38%ofthecontrolsweredeterminedto
be slow acetylators (5-acetylamino-6-amino-3-methyluracil/
1-methylxanthine [AFMU/1X] < 0.6), a prevalence higher
thanexpectedforthispopulation. Oncomparisonwithfast
acetylators, the risks (odds ratio, OR) for bladder cancer
among intermediate and slow acetylators were 1.4 [95%
confidence interval (CI): 0.4-5.1) and 1.2 (95% CI: 0.4-4.0),
respectively. When corrected for differences in the level of
benzidine exposure, the respective risks were OR = 1.8
(95% CI: 0.4-7.9) and OR = 1.5 (95% CI: 0.4-5.5). Neither
ofthese results is statistically significant, and there is no
evidence of a trend in risk. Similar analyses were carried
out,adjustingforage,city,andhistoryoftobaccouse,with
no important change in the findings. Urinary cotinine
levels and questionnaire-derived currenttobaccousewere
correlated, but neither influenced acetylator phenotype.
No associationwasfoundbetweenacetylatorphenotype
andbladder cancerrisk. Because ofthe highprevalence of
the slow acetylator phenotype in the control series and
because of our concern that bladder cancer itself may
affect the phenotyping procedure, we are currently
attempting to verify this finding in the same population,
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usingdapsone and anotherphenotypingprocedure (17), as
well as acetylation genotyping (18). Recentanalyses ofthe
genetic mutations associated with the slow acetylator
phenotype point to a different pattern of mutations in
Europeans and Asians (18).
Benzene and Leukemia Risk
A number of epidemiologic studies have shown an
increased risk for leukemia in occupational groups
exposed to benzene (19,20). In a collaborative project
between the National Cancer Institute andY. Songnian of
the Chinese Academy ofPreventive Medicine, more than
70,000 subjects occupationally exposed to benzene be-
tween 1971 and 1985 in 12 cities in China were identified.
Occupationalhistorieswereabstractedforstudymembers
for the period ofemployment in the studyfactories. Avail-
able data on measurements of exposure to benzene and
information onindustrialprocessesandindustrialhygiene
practices were obtained. Data on occupational historyand
on industrial exposures were used to estimate job- and
period-specific exposures.
As determined from routine examinations ofperipheral
blood at the factory, almost 1000 subjects had benzene-
relatedleukopenia, definedbyChinesenationalcriteria(Y.
Songnian, personal communication) as occupational ben-
zenepoisoning. Subjectswith andwithoutbenzenepoison-
ing were followed for the development of leukemia. In
preliminary analyses, the leukemia rate is about 20-fold
higher in subjects with benzene poisoning. Is benzene
poisoning amarkerforhigh-levelbenzene exposure orisit
an intermediate end point in the benzene-leukemia rela-
tionship (21),whichidentifies subjectswhohaveundergone
a biologic change leading to disease susceptibility?
Adetailedexposure assessmentisnowbeingcarriedout
to determine the history ofbenzene exposure ofthe study
subjects. The risk for benzene poisoning will be studied
with respect to period and level of benzene exposure.
Following this, the relationship between benzene expos-
ure, benzene poisoning, and leukemia will be studied. We
will explore the extent towhich benzene poisoning affects
leukemia risk, independent of the amount of benzene
exposure: that is, to what extent is benzene poisoning a
simple surrogate for benzene exposure or an independent
risk factor for leukemia? The resolution ofthis issue is of
central importance in assessing the relationship between
benzene dose and leukemia response. Further work to
characterizeindividual susceptibility to theeffects ofben-




We have carried out a study ofgenetic polymorphisms
associated with bladder cancerrisk inworkers exposed to
aromatic amines and are proceeding with a study of
benzene poisoning as an intermediate end point in leuke-
mia development. In the following sections I describe a
number ofmethodologic issues related to the execution of
these and similar studies.
Population Ascertainment
Studies of occupation and the risk of cancer require
ascertainment ofpopulationswhichhave experienced sub-
stantial occupational exposure to substances of interest
over extended periods oftime, generally several decades.
Thanks to gains made in occupational health and safety,
the number ofworkers with high exposures has substan-
tially decreased. The study populations for our work on
benzidine and benzene exposure were recruited in collab-
orationwith Chineseinvestigators. Benzidineusein China
wasdiscontinued in1972, andbenzeneexposure hasmark-
edly decreased over the past decades. While this trend is
clearly to be applauded, the unique remaining oppor-
tunities to studythe effects ofthese and othersubstances
ofinterest atsubstantial levels ofexposuremustbeidenti-
fied soon.
Disease Frequency
One major difference that distinguishes the epidemio-
logic approachfromotherapproaches to human disease is
the concept of disease frequency in a defined population.
Forexample, in aprospective studyto comparethe rate of
leukemia in subjects with and without benzene poisoning,
it is necessary to determine both the number of subjects
(denominator) andthenumberofleukemiacases (numera-
tor) in each group. In a case-control study, such as the
biochemical component of the benzidine study, cases
should represent a sample ofall cases ofinterest and the
controls should represent a sample ofthe population from
which the cases arose.
Aspartofalargelyobservational science, epidemiologic
investigations are subject to a number ofpitfalls, most of
which relate to errors in the estimation ofrelative disease
frequency between comparison groups. For example, if
knowledge about leukemia occurrence had influenced the
categorization of subjects as having had benzene poison-
ing, a biased estimate ofthe frequency ofleukemia in the
benzene-poisoned groupwould haveresulted. In the case-
control study of benzidine-exposed workers, only preva-
lent, surviving cases were included for analysis. If, for
example, bladder cancer cases who were slow acetylators
had poorer survival, the risk ofbladder cancerin the slow
acetylator groupwvould be underestimated.
Disease Susceptibility
Disease susceptibility has been assessed in epidemio-
logic studies of cancer in the past by analysis offamilial
association (22) and otherpossiblegeneticindicators, such
as race. The goals of these studies have been to identify
populations susceptible to disease and to model the rela-
tionship between exposure, disease susceptibility, and
occurrence of disease. Observed familial associations
could be due in part to clustering ofexposure risk factors
in the presumed genetic susceptibility risk groups, but
genetic factors probablyplay an important role in causing
familial aggregation (23).
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The' ability to detect environmental risks may be dra-
matically limited by unmeasured genetically determined
heterogeneity in susceptibility (24). The power of epi-
demiologic studies to identify human carcinogens will be
greatlyincreased as markers ofdisease susceptibility are
established, allowingforthe separation ofpeople atriskof
cancer from those not at risk. The biologic basis for
heterogeneity in the metabolism ofxenobiotics is becom-
ing better understood, and phenotypic and genotypic
markers for metabolic susceptibility to cancer in associa-
tionwith specific exposures are currently being assessed,
as described in this volume. Susceptibility to cancer may
also be due to the inheritance of mutated cancer sup-
pressor genes (25,26). This model may have general sig-
nificance but has not yet been substantiated for the
common tumors.
Epidemiologists are accustomed to analyzing the rela-
tionship between multiple factors in disease development.
For example, methods have been developed to assess the
interrelationship ofoccupation and smokingintheireffect
on cancerrisk (27). Molecular susceptibilityfactors canbe
modeled in a similar way in epidemiologic studies as
modifiers ofthe effect ofexposure.
Inthestudyofbenzidine-exposedworkers,wewereable
toclassifysubjectsbyhistoricalexposure tobenzidine and
by their ability to N-acetylate a test compound. This
allowed statistical modeling of the effect of these factors
on disease risk. The results do not supportthehypothesis
that N-acetylation is an important metabolic pathway for
benzidine-associated bladder cancer, at least in this popu-
lation.
Occupational and Other Exposures
In some investigations, the most difficult area of epi-
demiologic studyisthe assessment ofexposure because of
the complex, and often poorly understood, relationship of
disease development to dose, as expressed by level and
period of exposure. Information onjob title and industry
forms the basis for estimates of occupational exposure.
Historical information, based upon industrial process and
industrial hygiene measurements, can provide further
detailonoccupationalexposures. Contemporaryindustrial
hygiene studies can also be carried out to validate histor-
ical exposure estimations.
Epidemiologic studies of occupation and cancer risk
have relied upon retrospective estimation ofoccupational
exposure. Information on level and period ofexposure has
been used to assess dose-response relationships and to
evaluate the temporal relationship between exposure and
disease response. As in our studies of benzidine- and
benzene-exposed workers, these efforts are often limited
by the availability ofhistorical information on occupation
and the related periods and levels of exposure (28). No
molecular marker has been proposed, however, as a rea-
sonable substitute forsuchhistorical information.Atbest,
such a marker would provide an indication of cumulative
exposure but would not provide information about the
temporal sequence of exposure. Molecular markers could
be used in prospective cohort studies to characterize
exposure as it occurs, or biologic material could be stored
for later analysis in a "nested" case-control study. These
designs are being used for large-scale population studies
but have not yet been used in the occupational setting.
Some exogenous exposures mayhave mutational specif-
icity, causing specific "signature" changes in DNA (29,30).
Ifthis approach proves sufficiently sensitive and specific,
exposures could be determined qualitatively by examina-
tion of tumor DNA for these changes. This could be
particularly usefulfor suggesting newcarcinogens ornew
tumor sites for known carcinogens. Also, the ability to
discriminate exposure-related from"spontaneous"tumors
would in principle allow for greater specificity in examin-
ing dose-response relationships.
The principal use ofmolecular markers ofoccupational
exposure is in cross-sectional or short-term longitudinal
studies which can provide important insight by relating
external exposure to internal exposure and to intermedi-
ate markers of effect (2-4). Further, molecular markers
may allow validation of information from questionnaires
and other sources; for example, serum cotinine levTels can
be used to assess the validity of questionnaire data on
current tobacco use.
In molecular epidemiologic studies, other instruments
such as questionnaires forthe collection ofhistoricalinfor-
mation on diet, tobacco use, and other factors may need to
be developed. Such auxiliaryinformation maybe crucial to
the interpretation ofa studyand deserves the same atten-
tion to detail as the development oflaboratoryprocedures.
The data collected should, as much as possible, reflect the
amount and period of exposure. This information should
then be used appropriately in the analysis. For example,
pack-years, orcumulativeuse oftobacco, is anappropriate
measure of historical tobacco use but not of current
tobacco use.
Validity of Findings
In studies on the etiology ofcancer, error in the depen-
dentvariable, disease, is generally not substantial; errors
in the independent variables are of greater importance.
Error in estimating biologic parameters may be due to
limitations of biologic assay methods. In epidemiologic
fieldstudies, furthererrorsinbiologic determinations may
be due to limitations, under field conditions, in overall
study design and in collection, shipment, and storage of
samples. Other types ofmisclassification can derive from
errors in determination of important factors such as
occupation-related exposure, tobacco use, and diet.
It is useful to consider measurement error as either
differential or nondifferential. Differential measurement
errors occurwhenthe actofmeasurementisinfluencedby
studygroup status,resultinginbiasedfindings. Forexam-
ple in the case-control study ofbladder cancer, the deter-
mination of the acetylator phenotype of the cases could
have been biased because ofthe effect ofelevated urinary
pH in cystectomy cases on caffeine metabolites. A phe-
notyping procedure in serum, for, e.g., dapsone, would
address this potential problem.
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Nondifferential error can be random, related to preci-
sion, and systematic, related to accuracy. Nondifferential
error in precision, while not to be ignored, may be less
problematic in epidemiologic studies than in clinical
research, because the absolute value ofthe measurement
is less important than the ability to identify group dif-
ferences. Random error directly affects study power and
biases the result toward the null value (31). In more
complex situations where, for example, exposure status
and disease susceptibility are beingexamined as indepen-
dent variables determining disease status, errors ofmea-
surement can result in unpredictable results (32). Clearly,
attention to reduction in measurement error is valuable in
both the fleld and laboratory phases of molecular epi-
demiologic studies. Multiple repeats ofanalytic runs is an
established technique for reducing laboratory variability.
Only recently has attention been given in epidemiologic
investigations to the use of multiple measures (33) and
validation substudies (34) to reduce misclassification.
Inthebenzidine study,weareattemptingtovalidatethe
acetylation phenotyping carried out with caffeine by
retesting the study subjects with another phenotype test
drug. Planned genotype assays may provide further
insight into the study findings. Although the criteria for
benzene poisoning are established in China, their imple-
mentation may vary. We are planning further studies to
assess the presence of benzene poisoning in leukemia
cases and controls.
Independent verification of flndings in another labora-
tory is generally considered strong confirmation of an
experimental finding. Because ofthe observational nature
ofepidemiologic investigations, itis critical to repeatstud-
ies in several settings. Often, findings will not be entirely
consistent between studies and will thus require consider-
able judgment in deriving overall conclusions. The incon-
sistency in studies of N-acetylation and bladder cancer
riskinaromaticamine-exposed populationsillustrates this
point. We plan to pursue these issues in studies in other
populations.
This manuscript was presented at the Conference on Biomonitoring
and Susceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and Risk Assessment that was held in Kailua-Kona,
Hawaii, 26 October-1 November 1991.
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